Greenfield Robotics Launches a $2.07 Reg A Mini IPO for Farm Robots
A mini IPO is the informal name for a Regulation A offering that lets a private company sell shares to the general public without a full S-1 registration, and on September 10, 2026, Greenfield Robotics Corp filed the final offering circular for one built around weed-control robots for row-crop farms.
What happened
Greenfield Robotics filed its offering circular on Form 253G2 under file number 024-12773 on September 10, 2026. EDGAR records show the company had filed its Form 1-A offering statement in June, so the September document marks the move from review to a live Tier 2 offering.
The company offers up to 8,987,237 shares for cash at $2.07 per share. Up to 1,932,367 bonus shares may be issued at no added cost, and selling stockholders may sell up to 674,599 shares, bringing the total to as many as 11,594,203 shares. The maximum offering amount, including the value of bonus shares and transaction fees, is $24,700,000.23.
The minimum investment is 242 shares, or $500.94, plus a 3.5% transaction fee, for a total of $518.47.
The business is agricultural automation. Greenfield’s core product, the BOTONY robot, is designed for broadacre crops and offers chemical-free weed control and micro-spraying. The company frames its mission around replacing chemicals with autonomous machines to support regenerative farming.
How it works
StartEngine Primary, LLC acts as placement agent and collects the 3.5% transaction fee, while StartEngine Crowdfunding, Inc. provides administrative and technology services. That is a common pattern for consumer-facing Regulation A raises: a FINRA-registered intermediary handles the sale through an online portal.
Bonus shares of up to 20% are available based on factors such as investor status, holding a product reservation, prior investment in the company, a customer relationship, or investment size. Bonus shares lower the effective price per share for those who qualify, and they dilute those who do not.
The circular’s financial section is sobering. For 2025, Greenfield reported a net loss of $2,943,040. Its accumulated deficit at December 31, 2025 was $16,745,073, and cash on hand was $759,655. The auditor’s assessment notes substantial doubt about the company’s ability to continue as a going concern. The filing also discloses Kansas Angel Investor Tax Credits of up to $325,849.90 under a May 2022 agreement.
Proceeds are slated for manufacturing and production, field operations, research and development, sales and marketing, general and administrative costs, and working capital.
Key terms
- Mini IPO: A Regulation A public offering, usually smaller than a traditional IPO and often sold online.
- Tier 2: Allows up to $75 million in 12 months, preempts state registration, and requires ongoing reports on Forms 1-K, 1-SA and 1-U.
- Placement agent: The broker-dealer that markets the shares for a fee without committing to buy them.
- Transaction fee: A charge paid by the investor on top of the share price, here 3.5%.
- Going concern doubt: A warning that the company may not meet obligations over the next year without new capital.
FAQ
How is a mini IPO different from a traditional IPO?
A traditional IPO uses an S-1 registration, an underwriting syndicate and usually an exchange listing. A Regulation A mini IPO uses a lighter offering circular, can be sold directly online and, as here, may have no listing at all.
What does the cash figure tell investors?
With $759,655 in cash at year-end 2025 against a $2.9 million annual loss, the company depends on this raise to keep operating, which the going-concern language reflects.
Who can invest?
Tier 2 offerings are open to the public. Non-accredited investors are limited to 10% of the greater of annual income or net worth unless the shares are listed on an exchange.
What should readers watch?
Form 1-K and 1-SA reports will show how much was raised, how quickly the company is spending, and whether BOTONY deployments translate into revenue.
Prepared with AI assistance from public sources and reviewed under our editorial policy. Not investment advice.

